Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Hands holding a glass lung

Comparison of iRECIST and RECIST 1.1 for Evaluating Immunotherapy in Melanoma and Non-Small Cell Lung Cancer

In a retrospective study conducted at the University Hospital Cologne, the radiological criteria iRECIST and RECIST 1.1 were compared for assessing treatment response in melanoma and NSCLC patients receiving immune checkpoint inhibitors.

The results indicate that iRECIST is better suited for capturing atypical treatment responses to immunotherapies, especially in patients experiencing pseudoprogression. iRECIST could thus contribute to a more accurate evaluation of treatment response and improved immunotherapy outcomes.

Read more about the study here.

Clinical Research Standardized Reading Procedures iRECIST RECIST Research with mint mintLesion

Related Resources

Related Resources

This image shows a scan of pericardial effusion

Unveiling the Predictive Power of Pericardial Effusion in COVID-19 Outcomes

The COVID-19 pandemic wreaked havoc on healthcare systems worldwide, requiring a comprehensive understanding of disease progression for optimal…

This picture shows two men (one is a doctor) looking at a medical image within the program mint Lesion™

BZKF BORN Roll-Out Trainings in Full Swing

A first impression of the on-site BZKF BORN Roll-Out Trainings at LMU Klinikum München with our expert Steffen Rupp. The project is in full swing: the…

Picture shows a scan of pericardial effusion

RACOON: Study emphasizes the clinical relevance of pericardial effusion as an imaging biomarker in COVID-19 patients

A multicenter study [1] based on the German research infrastructure project RACOON (Radiological Cooperative Network of the COVID-19 pandemic; a Netzw…